Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on The Iceland Tribune.
Spain Tops FIFA World Rankings for First Time in Over 10 Years
(MENAFN) Spain surged to the summit of the latest FIFA Men’s World Ranking on Thursday, ending Argentina’s two-year dominance for the first time in over a decade. The reigning world champions dropped to third place behind France following a 1-0...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded data analysis from Phase 3 Stage 1 DIAMOND program for OCS-01 eye drops in diabetic macular edema (DME) to be...
Lobster Market Size USD 7.88 Bn in 2024 Trends, Share, Growth, Key Players & Forecast to USD 15.93 Bn | Seafood Insights
The Lobster Market was valued at USD 7.88 Bn. in 2024 and is expected to grow at a CAGR of 9.2% from 2025 to 2032, reaching nearly USD 15.93 Bn. by 2032. WILMINGTON, DE, UNITED STATES, September 22, 2025 /EINPresswire.com/ -- Explore the Lobster...
Multi-Day Elopements Rise for 2026 as Couples Turn Weddings into Immersive Adventures
Couples are trading one-day ceremonies for multi-day adventures, blending travel, culture, and love in unforgettable ways. REYKJAVIK, ICELAND, August 8, 2025 /EINPresswire.com/ -- Around the world, couples are re-imagining the way they say “I...
Oculis to Participate in Upcoming September Investor Conferences
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant...
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
Mark Kupersmith, M.D. appointed as Chief Medical Advisor, Neuro-Ophthalmology, following positive Phase 2 ACUITY trial results with Privosegtor (OCS-05) in acute optic neuritis and initiation of multiple programs in neuro-ophthalmology Sebastian...
Diabetic Retinopathy Market to Reach USD 17.82 Billion by 2034 as Diabetes Cases and Aging Population Rise
Ottawa, Sept. 17, 2025 (GLOBE NEWSWIRE) -- According to a study released by Towards Healthcare, a sister firm of Precedence Research, the diabetic retinopathy market was valued at USD 9.52 billion in 2024 and is anticipated to witness steady...
Global Leaders Converge in Edmonton September 23-25 for Carbon Capture Canada as Federal Government Expected to Boost Industrial Carbon Pricing in Fall 2025
EDMONTON, Alberta, Sept. 17, 2025 (GLOBE NEWSWIRE) -- As Canada accelerates its infrastructure agenda and doubles down on clean energy investments, Carbon Capture, Utilization and Storage (CCUS) has emerged as a cornerstone of the nation’s climate...
Oculis Reports Q2 2025 Financial Results and Provides Company Update
Focused execution in Q2 2025 to advance Oculis’ pipeline in ophthalmology and neuro-ophthalmology OCS-01: Both pivotal Ph3 DIAMOND trials are fully enrolled, with topline results expected in Q2 2026 for the first potential eye drop to treat...
inteliLIGHT cabinet controllers, making smart street lighting more accessible
When it comes to upgrading street lighting, not every city can or should start from scratch BRASOV, ROMANIA, September 16, 2025 /EINPresswire.com/ -- Many towns, suburbs and even large urban districts are looking for solutions that are...
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on comprehensive analytical,...
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq...
Jury lineup announced and tickets for the 2nd GEG Macao International Shorts Film Festival now on sale
MACAU, September 11 - Jointly organised by the Cultural Affairs Bureau (IC, from the Portuguese acronym) and Galaxy Entertainment Group (GEG), the 2nd Galaxy Entertainment Group Macao International Shorts Film Festival (hereafter referred to as...
Owner: Macau Government
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
REYKJAVIK, Iceland, July 10, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda...
Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet...
Six Weeks Until the Scandinavian & Nordic Gaming Show 2025 – Chairperson Shares Key Market Developments
STOCKHOLM, SWEDEN, September 12, 2025 /EINPresswire.com/ -- With just 6 weeks remaining, the 7th annual Scandinavian & Nordic Gaming Show 2025 is set to unite the region’s leading regulators, operators, and innovators on one prestigious...